Most Recent
High Court declines Rebel Wilson appeal in defamation case
Rebel Wilson has lost a bid to have the High Court reconsider an appeals court's decision to slash her record $4.75 million award in a defamation case against Bauer Media to $600,000.
ACCC wins record $18M fine against property spruiker We Buy Houses
A court on Thursday hit property spruiker We Buy Houses and its sole director, Richard 'Rick' Otton, with a record $18 million in total fines for misleading property investors with claims they could learn to buy real estate for $1.
Network 10 to ‘fiercely defend’ Boss trade mark case by Fairfax
Network 10 told a court Thursday it would "fiercely defend" a trade mark case brought by Fairfax Media over 10's recent rebrand and its newly approved trade mark, 10 Boss.
Court draws blood in Becton, B. Braun catheter patent case
A court has delivered a loss for Germany-based B. Braun Melsungen, dismissing its allegations that US-based device manufacturer Becton Dickinson infringed three of its intravenous catheter patents and ruling the patents invalid.
Law firm in showdown with ATO over Black Saturday payouts
Maurice Blackburn's battle with the Australian Taxation Office over a tax bill on class action settlements for thousands of Black Saturday bushfire victims went to court Tuesday, and the landmark case may turn on whether or not the law firm's administration of the settlement distribution scheme counts as a business.
Ex-director of corporate insolvency firm ‘ambushed’ by partner, judge says
A judge has found the former director of Sydney-based insolvency practice CRS Warner Kugel is entitled to compensation after he was "ambushed" out of the firm in 2014.
Court rejects Westpac’s $35M settlement with ASIC
The Federal Court has thrown out a proposed $35 million settlement between ASIC and Westpac over responsible lending breaches, saying the agreement was "unworkable" and left the court in an "information vacuum".
Neurim fights to amend Circadin patent amid infringement case against generics
Drug maker Neurim Pharmaceuticals is battling to amend its Australian patent for the blockbuster sleeping pill Circadin over opposition from two generic pharmaceutical companies, which have accused Neurim of attempting to gain an unfair advantage by delaying the amendment bid until now.
Funder wants major role in common fund challenge
Litigation funder Regency Funding has sought leave to intervene as a major player in one of two challenges to the courts' powers to issue common fund orders in class actions, but it might have a fight on its hands.
Crown shouldn’t keep jailed ex-employees silent, court told
An attempt by Crown Resorts to block ex-employees from talking to class action lawyers about the casino giant's thwarted business in China was contrary to the public interest, a judge heard Monday.